Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Bladder muscle relaxant for painful urination and urgency. | Calms an overactive bladder. |
| Body system | Kidney & Bladder | Kidney & Bladder |
| Drug class | Bladder antimuscarinics | Bladder antimuscarinics |
| Supply | Prescription only | Prescription only |
| Main uses | Urinary urgency and pain, Cystitis symptoms (alongside antibiotics), Interstitial cystitis (off-label) | Overactive bladder, Bedwetting in children (second line), Excessive sweating (off-label) |
| How it works | Relaxes the bladder to reduce urgency and pain. | Relaxes the bladder so it holds more. |
| Starts working | 1 hour | — |
| Half-life | Not well defined | 2–5 hours |
| Typical adult dose | 200 mg three or four times a day. | 2.5–5 mg two or three times a day, or 5–20 mg modified-release once a day. |
| Forms | Tablet | Tablet, Modified-release tablet, Patch, Gel |
| Common side effects | Dry mouth, Dizziness, Nausea, Blurred vision | Dry mouth, Constipation, Blurred vision, Drowsiness |
| Serious side effects | Urinary retention, Confusion in older adults | Confusion in older people, Urinary retention, Overheating (reduced sweating) |
| Don't take if | Bowel or urinary obstruction; Glaucoma; Severe heart disease | — |
| Alcohol | Best to limit. Alcohol adds to dizziness. | — |
| Pregnancy | Use with cautionLimited data. | Use with cautionLimited data. |
| Breastfeeding | Use with cautionLimited data. | — |
| In use since | — | 1975 |
| Brand names | United Kingdom: UrispasIndia: Urispas, Flavoxate (generic)Australia: Urispas (discontinued) | United States: Ditropan XL, OxytrolUnited Kingdom: Lyrinel XL, KenteraIndia: Oxyspas, Cystran |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | G04BD02 | G04BD04 |
Taken together
- ModerateFlavoxate + Oxybutynin: High anticholinergic burden
Adding anticholinergic drugs increases dry mouth, constipation, urinary retention, blurred vision and confusion — and in older people, falls and possibly dementia risk.